Assessment of Anti-Diabetic Medications Adherence among Diabetic Patients in Sana’a City, Yemen: A Cross Sectional Study
Journal of Pharmaceutical Research International,
Background: Lack of adherence to anti-diabetic medications use is linked with suboptimal glycemic control which in turn leads to increase rate of diabetic complications. The adherence to anti-diabetic medications among adult diabetic patients in Sana'a city has not been yet evaluated.
Objective: This study, therefore, assessed the extent to which diabetic patients are adherent to their antidiabetic medications and explored the factors underlying such adherence attitude in Sana’a City, Yemen.
Methods: A cross-sectional method was conducted among a sample of 365 diabetic patients attending public and private hospitals from March to April 2017 in Sana'a City-Yemen. Random patients were selected and data regarding their treatment adherence were obtained using a questionnaire. Adherence to diabetes medications was measured using medication adherence index followed by structured interviews. Descriptive analysis was used to compare between different groups of diabetic patients. Bivariate analyses were conducted to evaluate the associations between clinical variables.
Results: The cross-sectional study included 365 patients (263 males; 102 females). A high level of medication adherence rate to anti-diabetic drugs in the present study was (70%). The adherence rate was not similar in both genders where males were more adherent than females. The most common reason for non-adherence was forgetfulness (n= 67; 61%). While the lowest factor for non-adherence was associated with ineffective (n= 7; 6%). Adherence was strongly associated with diabetes duration, monthly income, blood sugar monitoring, communication with physician, and patient’s knowledge regarding importance of medication use (p <0.05).
Conclusions: The degree of adherence in patients with diabetes in Sana’a to anti-diabetic medication was shown to be mostly suboptimal. The medication adherence levels are still crucial strategy for optimal treatment against diabetes. However, additional studies on strategies to improve adherence rate and health care should be carried out in the future.
- Diabetes mellitus
- medication adherence
- cross sectional study
- adherence rate
How to Cite
Al-Habori M, M Al-Mamari, A Al-Meeri. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors. Diabetes Research and Clinical Practice. 2004;65(3):275-281.
Diabetec A. Diagnosis and classification of diabetes mellitus. Diabetes care,Diabetec Assocation. 2014;37(Supplement 1):S81-S90.
WHO, Adherence to long term therapies, time for action. World Health Organization. 2003;221.
Sabaté E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.
Jimmy B, et al. Adherence to medications among type 2 diabetes mellitus patients in three districts of Al Dakhliyah governorate, Oman: A cross-sectional pilot study. Sultan Qaboos University Medical Journal. 2014;14(2):e231.
Arifulla M, et al. Patients’ adherence to anti-diabetic medications in a hospital at Ajman, UAE. The Malaysian journal of medical sciences: MJMS. 2014;21(1):44.
Bakar ZA, Fahrni ML, Khan TM. Patient satisfaction and medication adherence assessment amongst patients at the diabetes medication therapy adherence clinic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016;10(2, Supplement 1):S139-S143.
Wong MCS, et al. Adherence to Oral Hypoglycemic Agents in 26 782 Chinese Patients: A Cohort Study. The Journal of Clinical Pharmacology. 2011;51(10):1474-1482.
Wabe N, M Angamo, S Hussein, Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. North American Journal of Medical Sciences. 2011;3(9):418-423.
Jarab AS, et al. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. International Journal of Clinical Pharmacy. 2014;36(4):725-733.
Raum E, et al. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes research and clinical practice. 2012;97(3): 377-384.
Ho PM, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of internal medicine, 2006;166(17):1836-1841.
Bailey CJ, KM. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011(22): 65:314.
Carratalá‐Munuera M, et al. Barriers associated with poor control in S panish diabetic patients. A consensus study. International journal of clinical practice, 2013;67(9):888-894.
Hutchins V, et al. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Current Medical Research and Opinion. 2011;27(6):1157-1168.
Kalyango JN, E Owino, AP Nambuya, Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. African Health Sciences. 2008;8(2).
Donnan P, T MacDonald, A Morris. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabetic Medicine. 2002;19(4):279-284.
Bagonza J, E Rutebemberwa, W Bazeyo, Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Services Research. 2015;15(1): 168.
Khan AR, et al. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine. 2012;19(1):26.
Sankar UV, et al. The adherence to medications in diabetic patients in rural Kerala, India. Asia Pacific Journal of Public Health. 2015;27(2):NP513-NP523.
Ahmad NS, et al. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference and Adherence. 2013;7:525.
Manobharathi M, P Kalyani, A Arulmani. Factors associated with therapeutic non-compliance among type 2 diabetes mellitus patients in Chidambaram, Tamilnadu, India. International Journal Of Community Medicine And Public Health, 2017;4(3):787-791.
Shobhana R, et al. Patients' adherence to diabetes treatment. The Journal of the Association of Physicians of India. 1999; 47(12):1173-1175.
EI-Hadiyah TM, et al. Factors affecting medication non adherence in type 2 Sudanese diabetic patients. Pharmacology & Pharmacy. 2016;7(04):141.
Karter AJ, et al. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Services Research. 2009;44(5p1):1640-1661.
Lee W, et al. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Managed Care Interface. 2006;19(7):31-41.
Park K, et al. Factors that affect medication adherence in elderly patients with diabetes mellitus. Korean Diabetes Journal. 2010;34(1):55-65.
Schectman JM, Mohan M. Nadkarni, John D. Voss, The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015-1021.
Gimenes HT, ML Zanetti, VJ Haas. Factors related to patient adherence to antidiabetic drug therapy. Revista Latino-Americana de Enfermagem. 2009;17(1): 46-51.
Grant RW, et al. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5): 1408-1412.
Mosnier-Pudar H, et al. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes & metabolism. 2009;35(3):220-227.
Yusuff KB, O Obe, BY Joseph. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharmacy World & Science. 2008;30(6):876-883.
Tiv M, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3):e32412.
Gill G. Diabetes in Africa-Puzzles and challenges. Indian Journal of Endocrinology and Metabolism. 2014;18 (3):249.
Abstract View: 599 times
PDF Download: 296 times